Health
Results: 3769-3780 of 8780

ClariMed Inc. Honored with 2025 Great Place To Work Certification™, Reflecting Human-Centered Culture

Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia

ESTEVE signs a licensing agreement for a severe primary insulin-like growth factor 1 deficiency treatment








